避孕

Curtis KM, Jatlaoui TC, Tepper NK, et al. US selected practice recommendations for contraceptive use, 2016. MMWR Recomm Rep. 2016 Jul 29;65(4):1-66.

• 全文
• 摘要

The Faculty of Sexual & Reproductive Healthcare (FSRH) of the Royal College of Obstetricians & Gynaecologists. UK Medical Eligibility Criteria for contraceptive use (UKMEC). May 2016 [internet publication].

• 全文

World Health Organization. Medical Eligibility Criteria for contraceptive use (MEC). 5th ed. 2015.

• 全文
• 摘要

Curtis KM, Tepper NK, Jatlaoui TC, et al; Centers for Disease Control and Prevention. US Medical Eligibility Criteria (USMEC) for contraceptive use, 2016. MMWR Recomm Rep. 2016 Jul 29;65(3):1-103.

• 全文
• 摘要

Stewart FH, Harper CC, Ellertson CE, et al. Clinical breast and pelvic examination requirements for hormonal contraception: Current practice vs evidence. JAMA. 2001 May 2;285(17):2232-9.

• 摘要

1.  Office for National Statistics. Conception statistics: conceptions in England and Wales 2016. March 2018 [internet publication].

• 全文

2.  National Institute for Health and Care Excellence. Long-acting reversible contraception. September 2014 [internet publication].

• 全文

3.  Hatcher R. Contraceptive technology. 20th ed. New York: Ardent Media; 2011.

• 全文

4.  Finer LB, Zolna MR. Declines in unintended pregnancy in the United States, 2008-2011. N Engl J Med. 2016 Mar 3;374(9):843-52.

• 全文
• 摘要

5.  Jones RK, Jerman J. Population group abortion rates and lifetime incidence of abortion: United States, 2008-2014. Am J Public Health. 2017 Dec;107(12):1904-9.

• 全文
• 摘要

6.  Jatlaoui TC, Shah J, Mandel MG, et al. Abortion surveillance - United States, 2014. MMWR Surveill Summ. 2017 Nov 24;66(24):1-48.

• 全文
• 摘要

7.  Curtis KM, Jatlaoui TC, Tepper NK, et al. US selected practice recommendations for contraceptive use, 2016. MMWR Recomm Rep. 2016 Jul 29;65(4):1-66.

• 全文
• 摘要

8.  The Faculty of Sexual & Reproductive Healthcare (FSRH) of the Royal College of Obstetricians & Gynaecologists. UK Medical Eligibility Criteria for contraceptive use (UKMEC). May 2016 [internet publication].

• 全文

9.  World Health Organization. Medical Eligibility Criteria for contraceptive use (MEC). 5th ed. 2015.

• 全文
• 摘要

10.  Curtis KM, Tepper NK, Jatlaoui TC, et al; Centers for Disease Control and Prevention. US Medical Eligibility Criteria (USMEC) for contraceptive use, 2016. MMWR Recomm Rep. 2016 Jul 29;65(3):1-103.

• 全文
• 摘要

11.  Stewart FH, Harper CC, Ellertson CE, et al. Clinical breast and pelvic examination requirements for hormonal contraception: Current practice vs evidence. JAMA. 2001 May 2;285(17):2232-9.

• 摘要

12.  Sawaya GF, Harper C, Balistreri E, et al. Cervical neoplasia risk in women provided hormonal contraception without a Pap smear. Contraception. 2001;63:57-60.

• 摘要

13.  The American College of Obstetricians and Gynecologists (ACOG). ACOG Committee Opinion No. 710. Counseling adolescents about contraception. August 2017 [internet publication].

• 全文

14.  White KO, Westhoff C. The effect of pack supply on oral contraceptive pill continuation: a randomized controlled trial. Obstet Gynecol. 2011 Sep;118(3):615-22.

• 摘要

15.  World Health Organization. Family planning - a global handbook for providers. 3rd edition. 2018 [internet publication].

• 全文

16.  Van Damme L, Ramjee G, Alary M, et al. Effectiveness of COL-1492, a nonoxynol-9 vaginal gel, on HIV-1 transmission in female sex workers: a randomised controlled trial. Lancet. 2002 Sep 28;360(9338):971-7.

• 摘要

17.  Stephenson J. Widely used spermicide may increase, not decrease, risk of HIV transmission. JAMA. 2000 Aug 23-30;284(8):949.

• 摘要

18.  Gaffield ME, Culwell KR, Lee CR. The use of hormonal contraception among women taking anticonvulsant therapy. Contraception. 2011 Jan;83(1):16-29.

• 摘要

19.  Lopez LM, Newmann SJ, Grimes DA, et al. Immediate start of hormonal contraceptives for contraception. Cochrane Database Syst Rev. 2012 Dec 12;(12):CD006260.

• 全文
• 摘要

20.  The Faculty of Sexual & Reproductive Healthcare (FSRH) of the Royal College of Obstetricians & Gynaecologists. Clinical guidance: quick starting contraception - April 2017. April 2017 [internet publication].

• 全文

21.  Burkman R, Schlesselman JJ, Zieman M. Safety concerns and health benefits associated with oral contraception. Am J Obstet Gynecol. 2004 Apr;190(4 Suppl):S5-22.

• 摘要

22.  Reid R, Leyland N, Wolfman W, et al. SOGC clinical practice guidelines: Oral contraceptives and the risk of venous thromboembolism: an update: no. 252, December 2010. Int J Gynaecol Obstet. 2011 Mar;112(3):252-6.

• 摘要

23.  Stegeman BH, de Bastos M, Rosendaal FR, et al. Different combined oral contraceptives and the risk of venous thrombosis: systematic review and network meta-analysis. BMJ. 2013 Sep 12;347:f5298.

• 全文
• 摘要

24.  Wu CQ, Grandi SM, Filion KB, et al. Drospirenone-containing oral contraceptive pills and the risk of venous and arterial thrombosis: a systematic review. BJOG. 2013 Jun;120(7):801-10.

• 全文
• 摘要

25.  The Faculty of Sexual & Reproductive Healthcare (FSRH) of the Royal College of Obstetricians & Gynaecologists. Clinical guidance: combined hormonal contraception - August 2012. August 2012 [internet publication].

• 全文

26.  ESHRE Capri Workshop Group. Noncontraceptive health benefits of combined oral contraception. Hum Reprod Update. 2005 Sep-Oct;11(5):513-25.

• 全文
• 摘要

27.  Iodice S, Barile M, Rotmensz N, et al. Oral contraceptive use and breast or ovarian cancer risk in BRCA1/2 carriers: a meta-analysis. Eur J Cancer. 2010 Aug;46(12):2275-84.

• 摘要

28.  Lopez LM, Grimes DA, Gallo MF, et al. Skin patch and vaginal ring versus combined oral contraceptives for contraception. Cochrane Database Syst Rev. 2013 Apr 30;(4):CD003552.

• 全文
• 摘要

29.  The Faculty of Sexual & Reproductive Healthcare (FSRH) of the Royal College of Obstetricians & Gynaecologists. Statement: venous thromboembolism (VTE) and hormonal contraception - November 2014. November 2014 [internet publication].

• 全文

30.  Shimoni N, Westhoff C. Review of the vaginal contraceptive ring (NuvaRing). J Fam Plann Reprod Health Care. 2008 Oct;34(4):247-50.

• 全文
• 摘要

31.  Abdel-Aleem H, d'Arcangues C, Vogelsong KM, et al. Treatment of vaginal bleeding irregularities induced by progestin only contraceptives. Cochrane Database Syst Rev. 2013 Oct 21;(10):CD003449.

• 全文
• 摘要

32.  World Health Organization. WHO statement on progestogen-only implants. 2015

33.  World Health Organization. Selected practice recommendations for contraceptive use. Third edition. Geneva:World Health Organization; 2016.

• 摘要

34.  The Faculty of Sexual & Reproductive Healthcare (FSRH) of the Royal College of Obstetricians & Gynaecologists. Clinical guidance: progestogen-only implants - February 2014. February 2014 [internet publication].

• 全文

35.  Guiahi M, McBride M, Sheeder J, et al. Short-term treatment of bothersome bleeding for etonogestrel implant users using a 14-day oral contraceptive pill regimen: a randomized controlled trial. Obstet Gynecol. 2015 Sep;126(3):508-13.

• 摘要

36.  The American College of Obstetricians and Gynecologists (ACOG). ACOG Committee Opinion No. 602. Depot medroxyprogesterone acetate and bone effects. June 2014 (re-affirmed 2017) [internet publication].

• 全文

37.  The Faculty of Sexual & Reproductive Healthcare (FSRH) of the Royal College of Obstetricians & Gynaecologists. Clinical guidance: progestrogen-only injectable contraception - December 2014. December 2014 [internet publication].

• 全文

38.  Anderson FD, Hait H. A multicenter, randomized study of an extended cycle oral contraceptive. Contraception. 2003 Aug;68(2):89-96.

• 摘要

39.  Edelman AB, Micks E, Gallo MF, et al. Continuous or extended cycle versus cyclic use of combined oral contraceptives for contraception. Cochrane Database Syst Rev. 2014 Jul 29;(7):CD004695.

• 全文
• 摘要

40.  Bosetti C, Bravi F, Negri E, et al. Oral contraceptives and colorectal cancer risk: a systematic review and meta-analysis. Hum Reprod Update. 2009 Sep-Oct;15(5):489-98.

• 全文
• 摘要

41.  Lyus R, Lohr P, Prager S, et al. Use of the Mirena LNG-IUS and Paragard CuT380A intrauterine devices in nulliparous women. Contraception. 2010 May;81(5):367-71.

• 摘要

42.  The Faculty of Sexual & Reproductive Healthcare (FSRH) of the Royal College of Obstetricians & Gynaecologists. Clinical guidance: intrauterine contraception - October 2015. October 2015 [internet publication].

• 全文

43.  Grimes DA. Intrauterine devices and infertility: sifting through the evidence. Lancet. 2001 Jul 7;358(9275):6-7.

• 摘要

44.  Grimes DA. Intrauterine device and upper-genital-tract infection. Lancet. 2000 Sep 16;356(9234):1013-9.

• 摘要

45.  Okusanya BO, Oduwole O, Effa EE. Immediate postabortal insertion of intrauterine devices. Cochrane Database Syst Rev. 2014 Jul 28;(7):CD001777.

• 全文
• 摘要

46.  The American College of Obstetricians and Gynecologists (ACOG). ACOG Committee Opinion No. 670. Immediate postpartum long-acting reversible contraception. August 2016 [internet publication].

• 全文

47.  Black A, Guilbert E, Costescu D, et al. Canadian Contraception Consensus (Part 3 of 4): Chapter 7 - intrauterine contraception. J Obstet Gynaecol Can. 2016 Feb;38(2):182-222.

• 摘要

48.  Hubacher D, Lara-Ricalde R, Taylor D, et al. Use of copper intrauterine devices and the risk of tubal infertility among nulligravid women. N Engl J Med. 2001 Aug 23;345(8):561-7.

• 全文
• 摘要

49.  Nelson A, Apter D, Hauck B, et al. Two low-dose levonorgestrel intrauterine contraceptive systems: a randomized controlled trial. Obstet Gynecol. 2013 Dec;122(6):1205-13.

• 摘要

50.  Mosher WD, Martinez GM, Chandra A, et al. Use of contraception and use of family planning services in the United States: 1982-2002. Adv Data. 2004 Dec 10;(350):1-36.

• 摘要

51.  Lawrie TA, Kulier R, Nardin JM. Techniques for the interruption of tubal patency for female sterilisation. Cochrane Database Syst Rev. 2016 Aug 5;(8):CD003034.

• 全文
• 摘要

52.  Hillis SD, Marchbanks PA, Tylor LR, et al. Poststerilization regret: findings from the United States Collaborative Review of Sterilization. Obstet Gynecol. 1999 Jun;93(6):889-95.

• 摘要

53.  The Faculty of Sexual & Reproductive Healthcare (FSRH) of the Royal College of Obstetricians & Gynaecologists. Male and female sterilisation - September 2014. September 2014 [internet publication].

• 全文

54.  The American College of Obstetricians and Gynecologists (ACOG). ACOG Committee Opinion No. 695. Sterilization of women: ethical issues and considerations. April 2017 [internet publication].

• 全文

55.  Bhindi B, Wallis CJD, Nayan M, et al. The association between vasectomy and prostate cancer: a systematic review and meta-analysis. JAMA Intern Med. 2017 Sep 1;177(9):1273-86.

• 摘要

56.  Møller H, Knudsen LB, Lynge E. Risk of testicular cancer after vasectomy: cohort study of over 73,000 men. BMJ. 1994 Jul 30;309(6950):295-9.

• 全文
• 摘要

57.  Duan H, Deng T, Chen Y, et al. Association between vasectomy and risk of testicular cancer: a systematic review and meta-analysis. PLoS One. 2018 Mar 22;13(3):e0194606.

• 全文
• 摘要

58.  Meyer JL, Gold MA, Haggerty CL. Advance provision of emergency contraception among adolescent and young adult women: a systematic review of literature. J Pediatr Adolesc Gynecol. 2011 Feb;24(1):2-9.

• 摘要

59.  Jatlaoui TC, Riley H, Curtis KM. Safety data for levonorgestrel, ulipristal acetate and Yuzpe regimens for emergency contraception. Contraception. 2016 Feb;93(2):93-112.

• 摘要

60.  Piaggio G, Kapp N, von Hertzen H. Effect on pregnancy rates of the delay in the administration of levonorgestrel for emergency contraception: a combined analysis of four WHO trials. Contraception. 2011 Jul;84(1):35-9.

• 摘要

61.  Glasier A, Cameron ST, Blithe D, et al. Can we identify women at risk of pregnancy despite using emergency contraception? Data from randomized trials of ulipristal acetate and levonorgestrel. Contraception. 2011 Oct;84(4):363-7.

• 摘要

62.  Gemzell-Danielsson K, Kardos L, von Hertzen H. Impact of bodyweight/body mass index on the effectiveness of emergency contraception with levonorgestrel: a pooled-analysis of three randomized controlled trials. Curr Med Res Opin. 2015 Dec;31(12):2241-8.

• 摘要

63.  The Faculty of Sexual & Reproductive Healthcare (FSRH) of the Royal College of Obstetricians & Gynaecologists. Clinical guidance: emergency contraception. December 2017 [internet publication].

• 全文

64.  Glasier AF, Cameron ST, Fine PM, et al. Ulipristal acetate versus levonorgestrel for emergency contraception: a randomised non-inferiority trial and meta-analysis. Lancet. 2010 Feb 13;375(9714):555-62.

• 摘要

65.  Moreau C, Trussell J. Results from pooled phase III studies of ulipristal acetate for emergency contraception. Contraception. 2012 Dec;86(6):673-80.

• 全文
• 摘要

66.  Belden P, Harper CC, Speidel JJ. The copper IUD for emergency contraception, a neglected option. Contraception. 2012 Apr;85(4):338-9.

• 摘要

67.  Shen J, Che Y, Showell E, et al. Interventions for emergency contraception. Cochrane Database Syst Rev. 2017 Aug 2;(8):CD001324.

• 全文
• 摘要

68.  World Health Organization. Emergency contraception fact sheet. February 2018 [internet publication].

• 全文

69.  Yuzpe AA, Lancee WJ. Ethinylestradiol and dl-norgestrel as a postcoital contraceptive. Fertil Steril. 1977 Sep;28(9):932-6.

• 摘要